Submission Format

• Each application should specify whether it is for an oral or ePoster presentation.
• The Scientific Programme Committee may reassign submitted presentations between formats as per its discretion.

Submission Limit

• Only one presentation will be permitted by one designated presenter.
• Each abstract submission is limited to 250 words maximum. There are no restrictions as to the number of abstracts submitted.
• Abstracts submitted to other international meetings must not be submitted and will not be accepted.

Presenting Delegate

• The presenting author must be a registered congress delegate.
• Only the name of the presenting author will appear in the final congress programme.
• The presenting author must declare any Conflict-Of-Interest during the abstract submission process.

Language of Submission

• All abstracts must be submitted in English.
• Accepted abstract presenters will be given the option to present their abstract in either English, French or Spanish.

Category of Submission

• The submission category for the abstract should be as per the official listing.
• The one category considered most suitable for the presentation should be selected.

Acceptance Notification

• Presenters will be notified regarding acceptance of their abstracts and given a deadline by which to register.
• Failure to register in time may result in exclusion from the programme and IJGO supplement.

The total word limit for an abstract submission is 250 words maximum.
The online abstract form is divided into the following sections:

Objective

• Concise statement on why the study was conducted.

Method

• Location, number and type of human subjects, non-human species or material being studied.
• Design of the study and type of intervention.
• Principal assays or test(s) performed and the types of statistical analyses if appropriate.

Results

• Main findings and results should be reported.
• Results should be supported by statistical analysis where appropriate.

Conclusions

• Main conclusions of the study and significance of the results.
• How the results may affect patient management or understanding of the condition.

Important Caveats

• Proof read abstract carefully before submitting. They will be published in the IJGO supplement as submitted.
• Only use standard abbreviations if indicated.
• Abstracts stating merely that the results will be presented or discussed at the congress may be rejected.
• The use of tables and images in the abstract is not allowed.
• Submissions by email and post will not be accepted.
• If you experience any technical difficulties, please email figo [at] support.ctimeetingtech.com

Subject Categories for Submission of Abstracts

AB 1 Maternal Foetal Health

AB 1.1 Prenatal Diagnosis
AB 1.2 Imaging in Obstetrics
AB 1.3 Assessment of Foetal Wellbeing
AB 1.4 Medical Disorders in Pregnancy
AB 1.5 High Risk Pregnancy
AB 1.6 Foetal Therapy
AB 1.7 Pre-Eclampsia Health Syndrome
AB 1.8 Preterm Birth

AB 2 Clinical Obstetrics

AB 2.1 Antenatal and Postnatal Care
AB 2.2 Labour and Delivery
AB 2.3 Operative Obstetrics
AB 2.4 Infections in Obstetrics
AB 2.5 Obesity and Obstetrics
AB 2.6 Midwifery Care
AB 2.7 Neonatal Care
AB 2.8 Safety and surveillance of obstetric care

AB 3 General Gynecology

AB 3.1 Paediatric and Adolescent Gynaecology
AB 3.2 Gynaecological Care for the Older Woman
AB 3.3 Imaging in Gynaecology
AB 3.4 Benign Conditions in Gynaecology
AB 3.5 Infections in Gynaecology
AB 3.6 Obesity and Gynaecology
AB 3.7 Gender Affirming Care

AB 4 Operative Gynaecology

AB 4.1 Conventional and Benign Gynaecological Surgery
AB 4.2 Minimal Access Surgery including Robotic Surgery
AB 4.3 Innovations in Gynaecological Surgery
AB 4.4 Safe Surgical Techniques and Practices
AB 4.5 Breast Diseases and Surgery

AB 5 Reproductive Medicine

AB 5.1 Reproductive Endocrinology
AB 5.2 Management of Subfertility
AB 5.3 Male Infertility
AB 5.4 Assisted Reproduction
AB 5.5 Disorders of Sexual Development

AB 6 Sexual and Reproductive Health and Rights

AB 6.1 Contraception and Family Planning
AB 6.2 Termination of Pregnancy
AB 6.3 Human Sexuality
AB 6.4 Sexual and Reproductive Rights
AB 6.5 Awareness and Counselling in Sexual and Reproductive Health
AB 6.6 Genetics and Reproductive Medicine

AB 7 Urogynaecology

AB 7.1 Preventive Urogynaecology
AB 7.2 Genital Prolapse – Management and Surgery
AB 7.3 Incontinence – Management and Surgery
AB 7.4 Genital Trauma and Fistulae

AB 8 Gynaecological Oncology

AB 8.1 Preventive Oncology
AB 8.2 Diagnosis and screening of malignancies
AB 8.3 Surgical treatment of malignancies
AB 8.4 Medical treatment of malignancies
AB 8.5 Novel/alternative/hormonal treatments
AB 8.6 Palliation, supportive care
AB 8.7 Infections and vaccinations

AB 9 Women’s Health Issues and Policy

AB 9.1 Health for All
AB 9.2 Addressing Maternal Mortality
AB 9.3 Sustainable Development Goals
AB 9.4 Medical Education and Training
AB 9.5 Information Technology in Women’s Health
AB 9.6 Ethics and Law in Women’s Health

AB 10 Special Topics

AB 10.1 Women and the Environment
AB 10.2 Climate Change
AB 10.3 Addressing Stigma and Violence against Women
AB 10.4 Women’s Health in Situations of Conflict and Disaster
AB 10.5 Research Methodology, Conduct and Dissemination
AB 10.6 Evidence Based Medicine and Guidelines
AB 10.7 Pandemic Infectious Diseases